Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)

  • STATUS
    Recruiting
  • End date
    May 12, 2026
  • participants needed
    300
  • sponsor
    Sanofi
Send
Updated on 25 February 2021
See if I qualify
atopy
dermatitis

Summary

Primary Objective:
To explore associations between biomarkers of atopic dermatitis (AD) and:
  • Disease state and time course of AD,
  • Disease state and evolution of selected atopic comorbid conditions,
  • Effectiveness of specific AD treatments.

Description

The estimated enrollment duration is approximately 2 years, while duration of observation is approximately 5 years.

Details
Condition ATOPIC DERMATITIS, eczema (atopic dermatitis), ATOPIC DERMATITIS, dermatitis, atopic, dermatitis, atopic, eczema (atopic dermatitis)
Age 13years - 34years
Treatment Blood sample, Cheek swab
Clinical Study IdentifierNCT03849716
SponsorSanofi
Last Modified on25 February 2021

Eligibility

 Yes No Not Sure

Inclusion Criteria

Participation in the OBS15333 pediatric atopic dermatitis (AD) registry
Signed informed consent by the parent/legally acceptable representative and assent by the participant appropriate to the participant's age

Exclusion Criteria

Not applicable
The above information is not intended to contain all considerations relevant
to a patient's potential participation in a clinical trial
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

atopy
dermatitis

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.